{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-114764","form_type":"8-K/A","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2026-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.927394+00:00","generated_at":"2026-05-15T09:36:26.364078+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Catalyst Pharma patent trial delayed to May 18, 2026 in NJ district court","bullets":["District Court of NJ delayed bench trial between Catalyst and Hetero USA from Mar 23 to May 18, 2026.","Trial concerns validity of Orange Book-listed patents for FIRDAPSE expiring in 2032, 2034, and 2037.","The trial is a bench trial (judge only) and will be held in the District of New Jersey."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-114764","json":"https://secwatch.observer/filing/0001193125-26-114764.json","markdown":"https://secwatch.observer/filing/0001193125-26-114764.md","text":"https://secwatch.observer/filing/0001193125-26-114764.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526114764/0001193125-26-114764-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526114764/d25173d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:36:26.364078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}